Stay updated with breaking news from Cumulative safety. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New data show proportions of patients treated with TREMFYA who achieved clinical-biomarker response ranged from 47.5-66.7 percent across dose grou. ....